Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 3
2007 3
2008 1
2009 5
2010 3
2011 2
2012 1
2014 1
2015 1
2016 2
2017 3
2018 6
2019 9
2020 18
2021 24
2022 23
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

97 results
Results by year
Filters applied: . Clear all
Page 1
Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review.
Fugazzaro S, Contri A, Esseroukh O, Kaleci S, Croci S, Massari M, Facciolongo NC, Besutti G, Iori M, Salvarani C, Costi S; Reggio Emilia COVID-19 Working Group. Fugazzaro S, et al. Among authors: costi s. Int J Environ Res Public Health. 2022 Apr 24;19(9):5185. doi: 10.3390/ijerph19095185. Int J Environ Res Public Health. 2022. PMID: 35564579 Free PMC article. Review.
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS. Feder A, et al. Among authors: costi s. Am J Psychiatry. 2021 Feb 1;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. Epub 2021 Jan 5. Am J Psychiatry. 2021. PMID: 33397139 Clinical Trial.
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, Iqbal T, Chadha N, Pizzagalli DA, Whitton A, Bevilacqua L, Jha MK, Ursu S, Swann AC, Collins KA, Salas R, Bagiella E, Parides MK, Stern ER, Iosifescu DV, Han MH, Mathew SJ, Murrough JW. Costi S, et al. Am J Psychiatry. 2021 May 1;178(5):437-446. doi: 10.1176/appi.ajp.2020.20050653. Epub 2021 Mar 3. Am J Psychiatry. 2021. PMID: 33653118 Free PMC article. Clinical Trial.
Looking Ahead in Pulmonary Rehabilitation.
Clini E, Costi S. Clini E, et al. Among authors: costi s. Front Rehabil Sci. 2021 Feb 11;1:615545. doi: 10.3389/fresc.2020.615545. eCollection 2020. Front Rehabil Sci. 2021. PMID: 36570603 Free PMC article. No abstract available.
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence.
Norbury A, Rutter SB, Collins AB, Costi S, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Glasgow AM, Brallier J, Shin LM, Charney DS, Murrough JW, Feder A. Norbury A, et al. Among authors: costi s. Neuropsychopharmacology. 2021 Dec;46(13):2266-2277. doi: 10.1038/s41386-021-01104-4. Epub 2021 Jul 31. Neuropsychopharmacology. 2021. PMID: 34333555 Free PMC article. Clinical Trial.
VATS Group ERAS Registry.
Vannucci J, Costi S, Matricardi A, Scarnecchia E, Droghetti A. Vannucci J, et al. Among authors: costi s. J Thorac Dis. 2018 Mar;10(Suppl 4):S571-S577. doi: 10.21037/jtd.2018.02.56. J Thorac Dis. 2018. PMID: 29629204 Free PMC article. Review.
Ketamine as a prophylactic resilience-enhancing agent.
Evers AG, Murrough JW, Charney DS, Costi S. Evers AG, et al. Among authors: costi s. Front Psychiatry. 2022 Jul 28;13:833259. doi: 10.3389/fpsyt.2022.833259. eCollection 2022. Front Psychiatry. 2022. PMID: 35966469 Free PMC article. Review.
97 results